|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 HKD | -1.55% |
|
-0.18% | -15.30% |
| Apr. 25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
| Apr. 10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Simcere Pharmaceutical Group. announced the appointment of Mr. Hongquan Liu, as its Chief Executive Officer and Executive Director of the Board, effective October 8, 2012. Mr. Jinsheng Ren will continue to serve as Chairman of Simcere.
Between 2000 and 2012, Mr. Hongquan Liu held the positions of Director and General Manager of Sino-Swed Pharmaceutical Corp. Ltd, the first pharmaceutical joint venture between China and Sweden.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.30% | 1.87B | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
SIMCERE PHARMACEUTICAL GROUP LIMITED 